Hit enter to search or ESC to close
Astante TherapeuticsAstante Therapeutics
  • Home
  • Team
  • Pipeline
  • Technology
    • Articles & News
  • Contact Us
All Posts By

Astante Team

Uncategorized

An Enzyme‐Directed Imidazoquinoline for Cancer Immunotherapy

Uncategorized

Comparing the immunogenicity of glycosidase-directed resiquimod prodrugs mediated by cancer cell metabolism

Uncategorized

An Enzyme-Directed Imidazoquinoline Activated by Drug Resistance

Recent Posts

  • An Enzyme‐Directed Imidazoquinoline for Cancer Immunotherapy
  • Comparing the immunogenicity of glycosidase-directed resiquimod prodrugs mediated by cancer cell metabolism
  • An Enzyme-Directed Imidazoquinoline Activated by Drug Resistance

Recent Comments

    • Home
    • Team
    • Pipeline
    • Technology
      • Articles & News
    • Contact Us

    Recent Posts

    • An Enzyme‐Directed Imidazoquinoline for Cancer Immunotherapy
    • Comparing the immunogenicity of glycosidase-directed resiquimod prodrugs mediated by cancer cell metabolism
    • An Enzyme-Directed Imidazoquinoline Activated by Drug Resistance

    © 2023 Astante Therapeutics.

    • Home
    • Team
    • Pipeline
    • Technology
      • Articles & News
    • Contact Us